Table 1.

Associations of BRD4 level with clinicopathologic parameters in GIST patients

	BRD4 expression		P
	Low level	High level
Gender			>.05
Male	109	43
Female	106	42
Age (y)	56.3 ± 14.33	58.4 ± 12.23	>.05
Location			>.05
Gastric	114	46
Nongastric	101	39
Tumour size (cm)	5.2 ± 2.34	6.5 ± 3.5	<.01
NIH risk			<.001
Low/very low	92	17
Intermediate	73	20
High	50	48
NCCN guideline			<.001
None/very low	72	4
Low	69	19
Moderate	36	14
High	38	48